Avience Biomedicals Limited IPO
Avience Biomedicals Limited was a SME IPO in the Medical Equipment & Supplies sector, offered at ₹196–₹208 per share to raise ₹30 crore. It listed on 25 Jun 2026 at ₹395 and closed its first day at ₹415, a listing gain of +99.5% versus the ₹208 issue price. It now trades around ₹253 (+21.7% versus the issue price).
Frequently asked questions
- What were the Avience Biomedicals Limited IPO listing gains?
- Avience Biomedicals Limited listed on 25 Jun 2026 at ₹395, closing its first day at ₹415 — a listing gain of +99.5% versus the ₹208 issue price.
- What was the price band and lot size of the Avience Biomedicals Limited IPO?
- The price band was ₹196–₹208 per share.
- Who were the registrar and lead manager for the Avience Biomedicals Limited IPO?
- Skyline Financial Services Private Limited was the registrar, and Fintellectual Corporate Advisors was the book-running lead manager.